Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

2010 The Lancet 1,003 citations

Keywords

WarfarinDabigatranMedicineAtrial fibrillationQuartileStroke (engine)Internal medicineRandomized controlled trialPopulationAnesthesiaConfidence interval

Affiliated Institutions

Related Publications

Publication Info

Year
2010
Type
article
Volume
376
Issue
9745
Pages
975-983
Citations
1003
Access
Closed

External Links

Citation Metrics

1003
OpenAlex

Cite This

Lars Wallentin, Salim Yusuf, Michael D. Ezekowitz et al. (2010). Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. The Lancet , 376 (9745) , 975-983. https://doi.org/10.1016/s0140-6736(10)61194-4

Identifiers

DOI
10.1016/s0140-6736(10)61194-4